Project Grant S10OD040120
- Federal Grant Award Summary Albert Einstein College of Medicine received a $220,042 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to procure a Miniaturized Two-Photon Microscope (Mini-2P) imaging system from Thorlabs, Inc. The award, effective May 15, 2026 through May 14, 2027, supports the acquisition of a state-of-the-art, lightweight, head-mounted microscopy system capable of high-resolution,...
- Federal Grant Award Summary Albert Einstein College of Medicine received a $750,000 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) on May 15, 2026, with a completion date of May 15, 2027. The award funds the acquisition of a new Schottky field emission scanning electron microscope (FE-SEM) with serial block-face imaging (SBF-SEM) capability for the Analytical Imaging Facility (AIF), a multi-user...
- Federal Project Grant Award Summary Albert Einstein College of Medicine received a $462,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2030. The award supports fundamental research establishing a novel therapeutic approach to inhibit protein-protein interactions through ligand-transferred oxidation. The research program focuses on...
- Federal Grant Award Summary Princeton University received a $1.476 million Project Grant from the National Institutes of Health Office of the Director under the Trans-NIH Research Support program (CFDA 93.310), awarded September 9, 2025, with completion scheduled for August 31, 2028. The award funds development of novel artificial intelligence and machine learning methods to advance cryo-electron microscopy (cryo-EM) and cryo-electron tomography (cryo-ET) image processing capabilities. The...
- Federal Grant Award Summary Albert Einstein College of Medicine received a $1.11M Project Grant award dated March 4, 2026, from the National Institute of Arthritis and Musculoskeletal and Skin Diseases under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award supports a 24-month research initiative focused on developing and validating a scalable imaging approach to measure muscle bioenergetics in patients with chronic kidney disease (CKD). The research...
- Federal Grant Award Summary Yale University received a $297,269 Project Grant from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire and implement an Olink proteogenomics instrumentation platform at the Yale Center for Genome Analysis (YCGA). The award, dated May 15, 2026, with a completion date of May 14, 2027, supports the expansion of YCGA's multiomics research capabilities by adding high-throughput, targeted...
- Federal Grant Award Summary Albert Einstein College of Medicine received a $462,000 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 7, 2025, with completion targeted for June 30, 2027. The research initiative focuses on designing improved T cell epitopes (antigenic peptides) to enhance the efficacy of T cell-based vaccines and adoptive cell therapies. The project will...
- Federal Grant Award Summary The National Institutes of Health Office of the Director awarded $405,787 to the University of Pennsylvania under the Research Infrastructure Programs (CFDA 93.351) to acquire and install an Asymmetric Field Flow Fractionation-Multiangle Light Scattering (AF4-MALS) system. This integrated analytical platform will be housed within the Johnson Foundation Structural Biology and Biophysics Core and will provide label-free separation and characterization capabilities for...
- Federal Grant Award Summary The Feinstein Institutes for Medical Research received a $1,628,062 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310), with an award date of June 15, 2025 and completion date of June 14, 2026. The grant funds the acquisition of a BD FACSymphony S6 SE spectral cell sorting platform to establish advanced high-parameter fluorescence-activated cell sorting (FACS)...
- Federal Grant Award Summary The University of Chicago received a $2.51 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded June 1, 2026, with completion targeted for May 31, 2030. This award funds research to advance Electric-Field Stimulated X-ray Crystallography (EFX), a nascent technology for observing protein dynamics at atomic resolution. The project will deliver hardware...
Albert Einstein College of Medicine received a $199,667 Project Grant from the National Institutes of Health Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to establish a Comprehensive Protein Stability Platform. The award, made on May 15, 2026, with a completion date of May 14, 2027, will support the acquisition and installation of an integrated analytical instrument combining full-spectral fluorescence monitoring, dynamic light scattering (DLS), and static light scattering (SLS) capabilities with automated plate reading, thermal cycling, and data reduction functionality. This instrumentation will serve as a shared core facility housed within the institution's research infrastructure. The platform will enable systematic assessment of protein stability and component interactions across multiple research domains, including immunomodulation, post-translational modifications, receptor-ligand interactions, phase separation and condensates analysis, medicinal chemistry screening, and translational therapeutics development. The instrument will support six major users and expand capabilities for ligand screening, structural biology investigations (X-ray crystallography, nuclear magnetic resonance, cryo-electron microscopy), and investigation of quaternary, quinary, and phase structural features in multi-channel mode. The facility will be managed by skilled and experienced core facility personnel to ensure reproducible and systematic research support across four National Institutes of Health-funded institutes at Einstein.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $199.7k | 5/7/26 |